Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Verrica Pharmaceuticals (VRCA) Return on Capital Employed (2021 - 2025)

Verrica Pharmaceuticals has reported Return on Capital Employed over the past 5 years, most recently at 0.44% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.44% for Q4 2025, up 410.0% from a year ago — trailing twelve months through Dec 2025 was 0.44% (up 410.0% YoY), and the annual figure for FY2025 was 0.36%, up 134.0%.
  • Return on Capital Employed for Q4 2025 was 0.44% at Verrica Pharmaceuticals, up from 1.48% in the prior quarter.
  • Over the last five years, Return on Capital Employed for VRCA hit a ceiling of 0.39% in Q1 2023 and a floor of 4.54% in Q4 2024.
  • Median Return on Capital Employed over the past 5 years was 1.24% (2022), compared with a mean of 1.59%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -363bps in 2024 and later soared 410bps in 2025.
  • Verrica Pharmaceuticals' Return on Capital Employed stood at 0.81% in 2021, then surged by 39bps to 0.49% in 2022, then tumbled by -86bps to 0.91% in 2023, then crashed by -400bps to 4.54% in 2024, then skyrocketed by 90bps to 0.44% in 2025.
  • The last three reported values for Return on Capital Employed were 0.44% (Q4 2025), 1.48% (Q3 2025), and 3.39% (Q2 2025) per Business Quant data.